Recent Press Releases

Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen

Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen Breakthrough Designation for daclatasvir and sofosbuvir...

Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue

Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue...

New Study Shows Inner-City Asthma Care Program Reduces Student Absenteeism by up to 20 Percent

RESEARCH TRIANGLE PARK, N.C., May 19, 2015 /PRNewswire/ -- New data from a school asthma management prog

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

- More Than 100,000 People with Coronary Artery Disease Have Been Treated with Absorb

PARIS, May 19, 2015

ASTELLAS AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED AT THE 2015 AMERICAN UROLOGY ASSOCIATION ANNUAL MEETING

TOKYO and SAN FRANCISCO – May 17, 2015 – Astellas Pharma Inc (TSE:4503) and Medivation, Inc (NASDAQ: MDVN) today announced data from the Phase 2 STRIVE trial comparing enzalutamide and...

Baxter and Baxalta Highlight Business Strategies at Investor Conferences

Companies Outline Vision for Accelerated and Sustainable Growth, Showcase InnovationSeparation into Two Independent Companies On-Track for Mid-Year 2015 DEERFIELD, Ill., May 18, 2015 (BUSINESS...

New US poll shows most parents (83%) want their teens and young adults to be vaccinated against meningococcal disease

Less than half of parents say they have talked to their child about how the disease is spread or its early symptoms - In 2015, meningococcal disease cases have been reported on college campuses...

Merck Starts a Challenging 2015 with a Solid First Quarter

Integration of AZ Electronic Materials, favorable currency environment and organic business drive overall net sales growth of 15.7% • Organic sales growth of 1.3% • EBITDA pre exceptionals...

Amgen Appoints Jonathan P. Graham Senior Vice President, General Counsel And Secretary

THOUSAND OAKS, Calif., May 18, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of <

Blue Cross Withholds Cure from Hepatitis C Patients, Lawsuit Claims

LOS ANGELES, May 15, 2015 /PRNewswire/ -- Shernoff Bidart Echeverria Bentley LLP filed a lawsuit in Los Angeles Superior Court today accusing Blue Cross of withholding a cure for Hepatitis C based...

Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader

Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader - Transaction valued at $8.05 billion is transformative for Endo, creating a powerful platform...

Amgen Presents First Phase 2 Data For AMG 334 In The Prevention Of Episodic Migraine

Patients Reported Significant Reductions in Monthly Migraine Days in First Dose-Ranging Study of CGRP Receptor Antagonist

THOUSAND OAKS,

AbbVie Receives Orphan Drug Designation for HUMIRA® (adalimumab) from the U.S. Food and Drug Administration for the Investigational Treatment of Moderate-to-Severe Hidradenitis Suppurativa (HS)

- Orphan Drug Designation program provides orphan status to medications intended for the safe and effective treatment, diagnosis or prevention of rare diseases - HS, a chronic, immune-mediated skin...

Takeda reports top line results in line with guidance, with underlying growth of +2.8%

EPS affected by one-time charges in FY2014 Back to profitable growth from FY2015 onward Operational guidance met Underlying revenue +2.8% year-over-year, in line with guidance (reported...

Amgen Announces Voting Results of Annual Meeting of Stockholders

THOUSAND OAKS, Calif., May 14, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced voting results

Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies

INDIANAPOLIS, May 14, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Sanford-Burnham Medical

Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio

THOUSAND OAKS, Calif., May 13, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data

Orexigen Therapeutics Provides Statement on Termination of the Light Study and Updates on Contrave Collaboration with Takeda Pharmaceuticals

SAN DIEGO, May 12, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today issued the following statement regarding the termination of the Light Study a cardiovascular (CV) outcomes...